A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Mills Peninsula Health Services · Florida State University · +86 more institutions
Abstract
A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data.
We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low-glucose and low-glucose hypoglycemia; very high-glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation.
Citation impact
- FWCI
- 32.79
- Percentile
- 100%
- References
- 32
Authors
94Topics & keywords
- Continuous glucose monitoring
- Hypoglycemia
- Medicine
- Blood Glucose Self-Monitoring
- Diabetes mellitus
- Index (typography)
- Internal medicine
- Intensive care medicine
- Good health and well-being
Funding
- AAmgen
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- ICInsulet Corporation
- MCMannKind Corporation
- DDexcom
- HTHorizon Therapeutics
- GPGlenmark Pharmaceuticals
- NNNovo Nordisk
- SServier
- RDRoche Diabetes Care
- NINational Institutes of HealthAwards: P30 DK098722, DK098722, NIH P30 DK098722
- UOUniversity of California, San Francisco
- ADAbbott Diabetes Care